Fig. 5From: Risk factors of immune checkpoint inhibitor-associated acute kidney injury: evidence from clinical studies and FDA pharmacovigilance databaseForest plot of associations between combination therapy and AKI in ICIs-treated patients. AKI Acute kidney injury, ICIs Immune checkpoint inhibitorsBack to article page